The susceptibilities of 27 Plasmodium falciparum strains to chloroquine and mefloquine were studied in the area of Puerto Ayacucho, Amazonas Federal Territory of Venezuela, to determine their levels of resistance in vivo and in vitro. 50% of these strains showed chloroquine resistance in vivo. No grade III chloroquine resistance was found. 25% of the strains were resistant to chloroquine in vitro and 9% were resistant to mefloquine in vitro. Preliminary results suggest that strains resistant to Fansidar may also be found.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0035-9203(89)90361-1DOI Listing

Publication Analysis

Top Keywords

strains chloroquine
12
plasmodium falciparum
8
falciparum strains
8
chloroquine mefloquine
8
amazonas federal
8
federal territory
8
territory venezuela
8
resistance vivo
8
chloroquine resistance
8
strains resistant
8

Similar Publications

Article Synopsis
  • Malaria is a significant global health issue caused by the Plasmodium genus, with drug resistance, particularly to chloroquine in P. vivax and P. falciparum, being a pressing concern in endemic regions of Africa.
  • The study aimed to assess the prevalence of molecular markers indicating chloroquine resistance in malaria parasites across East Africa through a systematic review and meta-analysis of relevant studies.
  • A total of 20 studies were analyzed, focusing on key molecular markers associated with chloroquine resistance, ultimately providing insight into the prevalence of these markers in malaria parasites.
View Article and Find Full Text PDF

TKK130 is a 3-Hydroxy-Propanamidine (HPA) with Potent Antimalarial Activity and a High Barrier to Resistance.

J Med Chem

December 2024

Heinrich Heine University Düsseldorf, Faculty of Mathematics and Natural Sciences, Institute of Pharmaceutical and Medicinal Chemistry, Universitätsstr. 1, 40225 Düsseldorf, Germany.

Malaria continues to pose a significant burden on populations in endemic areas and requires innovative treatment options. Here, we report the synthesis and preclinical evaluation of the novel 3-hydroxypropanamidine (HPA) , which shows excellent antiplasmodial activity against drug-sensitive and -resistant strains. Moreover, in various human cell lines, the compound shows no cytotoxicity and excellent parasite selectivity.

View Article and Find Full Text PDF

Agunmu (ground herbal medicine) is a form of West African traditional medicine consisting of a cocktail of herbs. The goal of this study is to evaluate a formulation of Agunmu made from , , , , and , sold in the open market and commonly used for the treatment of malaria by the locals, for its antimalarial effects and to determine the active principles that may contribute to the antimalarial effect. The ethanolic extract obtained from this formulation (Ag-Iba) was analyzed, using TLC, LC-MS, and Tandem-MS techniques, to determine its phytochemical properties.

View Article and Find Full Text PDF

Herein, we report the design, synthesis, and characterisation of a new library of enantiopure aminoalcohol fluorenes, as well as their in vitro evaluation for biological properties, including activity against two strains of P. falciparum (3D7 and W2) and cytotoxicity on the HepG2 cell line. All tested compounds exhibited good to excellent antimalarial potency with IC values ranging from 0.

View Article and Find Full Text PDF

Exploring the Antimalarial Potential of Leaf Extract Against in Mice.

J Trop Med

November 2024

School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat 80160, Thailand.

Malaria remains a critical global health issue, particularly in tropical and subtropical regions. The disease, caused by parasites, is transmitted by mosquitoes and can lead to severe complications and death if untreated. The emergence of drug-resistant strains highlights the urgent need for new antimalarial agents.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!